U.S. Chemicals Stock News

Earlier in May, Savara Inc. reported new Phase 3 IMPALA-2 data at the ATS 2026 meeting showing that nebulized molgramostim improved exercise capacity and related measures in adults with autoimmune pulmonary alveolar proteinosis, while also posting a wider quarterly net loss of US$37.28 million. The convergence of clinically meaningful functional gains in a rare lung disease and preparations ahead of an FDA Priority Review has sharpened attention on molgramostim’s potential role in the aPAP...

In recent months, NetScout Systems reported earnings that exceeded analyst expectations, reinforcing confidence in its operations and prompting analysts to revise earnings estimates higher. This pattern of positive surprises and upward estimate revisions has strengthened the perception that NetScout’s current execution may be better aligned with analyst expectations than previously assumed. With these earnings beats and higher forecasts in mind, we’ll now examine how this shift in...

Viasat (VSAT) is back in focus after securing a US$437.7 million government contract with Intelsat General Communications for the Protected Tactical Satellite Global program, a move that highlights its defense communications capabilities. See our latest analysis for Viasat. The contract win comes on top of a strong run in the stock, with a 30-day share price return of 20.28% and a 90-day gain of 55.59%, while the 1-year total shareholder return of around 7x suggests momentum has been building...

Recent analyst commentary on Inspire Medical Systems (INSP) has turned more cautious, highlighting reimbursement coding challenges and the need for clearer catalysts. This shift has brought renewed attention to the stock’s risk profile. See our latest analysis for Inspire Medical Systems. The recent caution from analysts comes after a period where the stock’s 30 day share price return is down 22.15% and the year to date share price return is down 52.49%, while the 1 year total shareholder...

If you are wondering whether Nasdaq at around US$91 a share is still a solid entry or more fully priced, this article walks you through what the current valuation suggests. The stock is down 1.7% over the past week and down 5.8% year to date, but it is up 12.6% over the past year and 75.1% over three years, which can signal shifting views on both its growth potential and risk. Recent coverage has focused on Nasdaq's role as a major market operator and its position in capital markets...

Revolution Medicines (RVMD) is back in focus after reporting positive Phase 3 RASolute 302 results for daraxonrasib in metastatic pancreatic ductal adenocarcinoma, highlighted in a Plenary Session at the 2026 ASCO Annual Meeting. See our latest analysis for Revolution Medicines. The stock has been volatile but firmly upward over the past year, with a 30 day share price return of 12.02%, a 90 day move of 44.58% and a very large 1 year total shareholder return, as data readouts and new coverage...

Recent performance snapshot for RBC Bearings stock Without a fresh company specific headline driving the move, RBC Bearings (RBC) has attracted attention after a year of strong longer term returns alongside a recent pullback over the past month. The stock is up about 55% over the past year and roughly 172% over the past 3 months, yet it has fallen about 5% over the past month and about 2% over the past 3 months, highlighting a mix of momentum and recent consolidation. See our latest analysis...

MasTec recently reported its strongest-ever first quarter, with revenues up 34%, adjusted EPS rising very sharply year over year, and a record US$20.30 billion backlog that led management to raise full‑year 2026 guidance for revenue, adjusted EBITDA, and EPS. Beyond the headline growth, the company’s 1.4x book‑to‑bill ratio and 28% year‑over‑year increase in its 18‑month backlog underline broad-based, longer‑term demand across Clean Energy, Infrastructure, and Pipeline projects. We’ll now...

Event overview and recent stock context Travelers Companies (TRV) recently drew investor attention as its stock performance over the past month and past 3 months contrasted with mixed annual revenue and net income trends, prompting a closer look at the insurer's current position. See our latest analysis for Travelers Companies. At a share price of $306.46, Travelers Companies has seen steady share price momentum this year, with a 7.46% year to date share price return and a 5 year total...

Brunswick (BC) stock gained 5.2% after easing bond market pressures and lower oil prices improved sentiment toward consumer-focused companies, drawing attention to how macro shifts intersect with this US$5.3b leisure and marine business. See our latest analysis for Brunswick. That 5.2% intraday move sits within a mixed picture, with a 7 day share price return of 5.87% and a 90 day share price return that is down 3.35%. The 1 year total shareholder return of 66.61% contrasts with a 5 year...

Recent performance snapshot Columbia Financial (CLBK) has drawn fresh attention after a period of solid share price gains. The stock closed at $20.36 and posted positive returns over the past month and past 3 months. For context, the stock shows a 12.1% return over the past month and 13.2% over the past 3 months. Year to date it is up 32.0%, and it has gained 43.4% over the past year, based on the figures provided. See our latest analysis for Columbia Financial. That recent upswing in the...

Earlier in May 2026, Innospec Inc. announced a 5.7% increase in its semi-annual dividend, authorized a new US$75.00 million share repurchase program, and reported first-quarter revenue up 3% year over year alongside lower adjusted EBITDA and EPS. An interesting angle is how Innospec is simultaneously returning more cash to shareholders and absorbing weaker profitability metrics, signaling management confidence despite mixed quarterly results. We’ll now examine how the higher dividend and new...

Tidewater recently saw its shares come under pressure after crude oil prices fell on reports of a potential U.S.–Iran peace draft, which eased geopolitical risk premiums and weighed on the broader offshore energy sector. Investor sentiment toward Tidewater was further affected by disappointing revenue news from a major offshore driller and recent insider share sales, even though these factors have not signaled a clear change in the company’s underlying business outlook. We’ll now examine how...

Earlier this month, Regions Financial Corporation’s shareholders approved Charter and By-Law amendments that removed certain supermajority voting rules, eased business combination restrictions, and expanded liability protections for specific officers, with these changes becoming effective between May 6 and May 11, 2026. These governance adjustments meaningfully shift how power is distributed between shareholders, management, and the board, potentially influencing future corporate decisions...

What LTC Properties stock performance tells you right now LTC Properties (LTC) has delivered mixed share performance, with the stock up about 0.6% over the past month but down roughly 1.5% over the past 3 months, prompting closer attention from income focused REIT investors. See our latest analysis for LTC Properties. At a share price of $38.48, LTC’s recent 1 day share price dip of 0.4% contrasts with an 11.1% year to date share price return and a 16.1% total shareholder return over one...

Rivian Automotive (RIVN) is back in focus after a recent downgrade to a sell rating, with concerns around risk reward, technical resistance, and margin pressure as the R2 production ramp gets underway. See our latest analysis for Rivian Automotive. Rivian’s share price has been volatile around the latest downgrade, with a 7 day share price return of 6.52% but a year to date share price return down 26.74%, while the 1 year total shareholder return is down 9.02%. This highlights ongoing...

IPO momentum and fixed income activity set the backdrop for GS stock Goldman Sachs Group (GS) is back in the spotlight as lead adviser on anticipated SpaceX and OpenAI IPOs, while recently issuing a series of new fixed income securities across multiple currencies and maturities. See our latest analysis for Goldman Sachs Group. GS shares have been firming up, with a 7.53% 1 month share price return and 10.47% 3 month share price return, while the 5 year total shareholder return of 201.10%...

In May 2026, BBRC International PTE Limited, a roughly 13% shareholder, escalated its proxy campaign at Victoria’s Secret & Co., urging investors to vote against long‑tenured Board Chair Donna James over governance, capital allocation, and oversight concerns ahead of the June 11 annual meeting. Victoria’s Secret has responded with its own presentations and the launch of VSPathtoPotential.com, arguing that its Path to Potential turnaround under CEO Hillary Super is gaining traction and that...

Chubb Limited’s 2026 Annual General Meeting in Switzerland approved a 5.2% increase in the annual dividend to US$4.08 per share, marking the 33rd consecutive yearly raise, alongside authorization of a new US$7.50 billion share repurchase program and issuance of US$1.00 billion in 5.300% senior notes due 2036. These capital allocation moves, combined with the launch of the Combined Cancer Care supplemental insurance product in Canada, highlight Chubb’s focus on income-focused shareholders...

Knife River Corporation recently amended its Credit Agreement, adding US$400 million to its term B loans at a slightly lower interest margin, bringing total term B borrowings to US$895 million, with proceeds earmarked for refinancing existing loans, repaying its revolving credit facility, and general corporate and working capital uses. On the governance side, the company reshaped its finance leadership by appointing longtime internal executive Peggy S. Rebstock as Vice President, Chief...

In May 2026, Harrow, Inc. reported first-quarter 2026 results showing revenue of US$44.2 million versus US$47.83 million a year earlier, with net loss widening to US$27.6 million and basic loss per share from continuing operations rising to US$0.74 from US$0.50. Despite weaker quarterly performance, Harrow set second-quarter 2026 revenue guidance of US$71 million to US$81 million and reaffirmed full-year 2026 revenue guidance of US$350 million to US$365 million, highlighting management’s...

Cardinal Health (CAH) stock has attracted fresh attention after recent performance data highlighted mixed returns, with gains over the past year but a decline over the past 3 months, prompting investors to reassess its current valuation. See our latest analysis for Cardinal Health. At a share price of $200.68, Cardinal Health’s recent share price return has been soft over the past 3 months, even though the 1 year total shareholder return of 32.86% and 5 year total shareholder return of...

In May 2026, Garrett Motion Inc. amended its credit agreement to lower interest rates on its USD term loan facility and reset six‑month soft call protection, while also becoming Ingersoll Rand’s multiyear partner to co-develop next-generation oil-free air technologies for critical industrial applications. Together, the cheaper debt and collaboration with Ingersoll Rand highlight Garrett Motion’s effort to refine its capital structure while expanding into higher-value, oil-free compression...

Event context and recent price performance Acadian Asset Management (AAMI) has been drawing attention after recent share price moves, with the stock up about 5.6% over the past month and about 31.7% over the past 3 months. See our latest analysis for Acadian Asset Management. At a share price of $71.58, Acadian Asset Management has seen short term share price momentum paired with a much stronger build in longer term total shareholder returns, with the 1 year total shareholder return of...